Prodotti competitors / Area HIV 14 febbraio 2025 APRETUDE Reimbursement Milestones in Scotland and Canada
Prodotti competitors / Area HIV 3 febbraio 2025 European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
Prodotti competitors / Area Oncology 31 gennaio 2025 Positive CHMP Opinion for Datopotamab Deruxtecan (Datroway) for the 2L+ treatment of unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer
Prodotti competitors / Area Onco-Ema, Area Kite 31 gennaio 2025 Positive CHMP Opinion for Breyanzi (liso-cel) for Relapsed or Refractory Follicular Lymphoma in 2L
Prodotti competitors / Area Oncology 31 gennaio 2025 FDA approval for trastuzumab deruxtecan for adult patients with unresectable or metastatic HR positive, HER2-low or HER2-ultralow breast cancer
Regulatory news Associazioni 28 gennaio 2025 European Health Data Space: Council adopts new regulation improving cross-border access to EU health data
Prodotti competitors / Area Liver 24 gennaio 2025 Assegnazione della qualifica di medicinale orfano a Volixibat nella Colangite Biliare Primaria (PBC).
Regulatory news 24 gennaio 2025 Catalent announces collaboration with Galapagos to further expand Galapagos’ Decentralized CAR-T Manufacturing Network
Autorità nazionali 20 gennaio 2025 NICE: International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis